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Background: We investigated the feasibility of shunt insertion procedures with acceptable 
short-term outcomes in Ethiopia, and to identify factors associated with good and bad 
outcomes. 
Methods: This is a hospital based prospective cohort study of outcome of 
ventriculoperitoneal shunt insertion at Myungsung Christian Medical center (MCM), Addis 
Ababa, Ethiopia in the period between January 2011 and December 2012. Medical records 
were reviewed in a structured questionnaire prepared for this purpose. Epidemiological 
data, head circumference, clinical investigations, etiology of the hydrocephalus, details of 
the ventriculoperitoneal(VP) shunt insertion, outcome by the end of 6 months, morbidity 
and mortality data were collected. Outcomes were graded as good, fair, or poor, according 
to head circumference, anterior fontanels status, visual, motor, and seizure criteria. 
Difference in proportions was examined using Chi-square test. 
Results: The Authors review141 VP shunt insertions in 114 patients≤ 12 years of ageatMCM, 
61(53.5%) were male and 46(46.5%) female. The median age was 3 months (range 0.3-
144); the mean head circumference at presentation was 50.4 ± 10.1cm (range, 34-106). The 
commonest causes of hydrocephalus were spina bifida (42.3%) and post infectious 
(20.2%). Early complications following surgery were seen in 65(58.0%) patients. The 
commonest complication was mechanical failure in 54(48.2%) patients, under shunting 
constituted 83.3% of the mechanical shunt failure, shunt infection being 7%. Follow-up was 
available in 75.4% of children, with a mean follow-up period of 6.8 ± 7.2 months (range 1-
36). In-hospital mortality was 1.8%. The overall shunt function rate at last visit was 88.3%, 
head circumference ≥ 50 cm had significant early complication compared to those with ≤ 50 
cm. Age and Sex were not significantly correlated to the occurrence of complications and 
outcomes. 
Conclusion: Spina bifida was main etiological cause of hydrocephalus. Our study has 
documented good outcomes at 12 months follow-up period for VP shunt insertion with 
acceptable early complication rates. However, children with a head circumference greater 
than 50 cm had significant early complication (p=0.028). Given the availability of fully 
subsidized VP shunts in a country with enormous number of hydrocephalic children, shunts 
will continue to play a pivotal role in the management of hydrocephalus in Ethiopia. 
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Introduction 
The prevalence and incidence of hydrocephalus in developed nations is estimated as 0.9-
1.2/1000 and 0.2-0.6/1000 respectively.1No reliable estimate is available in the African 
literature, but its incidence is likely higher because of untreated / poorly treated neonatal 
meningitis, congenital malformation and nutritional deficiencies. Some of several hypothesized 
causes of pediatric hydrocephalus include, congenital malformations, meningitis/ventricuitis, 
tumors, traumatic head injury or subarachnoid hemorrhage2,3. Two forms of hydrocephalus 
exist, communicating and non-communicating. The clinical exam is the most readily available 
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investigation for the diagnosis of hydrocephalus. Hydrocephalus and its complications such as 
shunt malfunction or infection are also regularly diagnosed by cranial imaging including 
ultrasonography, computed tomography (CT) or magnetic resonance imaging (MRI). The 
surgical treatments for hydrocephalus are inserting a shunt system to redirect the flow of 
cerebrospinal fluid (CSF) to other parts of the body or endoscopically diverting CSF from 
ventricular system to subarachnoid space. Despite the increasing use of endoscopic procedures 
in our centers, Ventriculoperitoneal (VP) shunt placement remains the principal method of 
treating hydrocephalus in Ethiopia. It is the gold standard against which newer procedures are 
judged. VP shunts are associated with substantial complication rates. Worldwide failure rates 
currently still range between 25% and 40% within the 1st year following insertion3-6. 
 
This was a prospective cohort study of patients who had undergone VP shunt surgeries with 
respect to etiology, complications and outcome. 
 
Materials and Methods 
This is a prospective study of 114 patients≤ 12 years with hydrocephalus who received VP 
shunt as primary treatment (93%) or VP shunt insertion following endoscopic third 
ventriculostomy (ETV) failure between January 2011 and December 2012 at Myungsung 
Christian Medical Center (MCM). Medical records were reviewed meticulously in a structured 
questionnaire prepared for this purpose. Epidemiological data, duration of symptoms, clinical 
investigations, etiology of the hydrocephalus, details of the VP shunt insertion, complications 
and outcome by the end of 6 months, and morbidity and mortality data were collected.  
All the shunts used were medium pressure shunts. Shunt complications were looked for during 
the follow up period, even though it was not always feasibledue to high dropout rate. 
Complications were generally put as Infectious, mechanical failure and seizure. Mechanical 
shunt failure can occur through proximal obstruction, distal obstruction, component 
separation/fracture/migration or excessive CSF drainage A ventricular tap was routinely 
carried out for majority of patients with infected/ ruptured spinal bifida andif infection is 
strongly suspected, CSF analysis was done, Gram stain test and cultures/ sensitivity were also 
obtained for those patients who presented with a elevated CSFwhite blood cell(WBC)count and 
protein values.  
 
The category post-infectious hydrocephalus(PIH)was used in cases in which one of the 
following criteria were met: 1) There was a clear history of meningitis, which was followed by 
onset of the hydrocephalus. 2) There was a history of a febrile illness, followed in closely by the 
onset of hydrocephalus. 3) Ultrasonography and CT scans demonstrated loculation/septations/ 
bands in the ventricles. Some of them were labeled as PIH after ETV. Non post-infectious (NPIH) 
included cases of congenital hydrocephalus due to aqueductal stenosis, Dandy-Walker 
malformation and other congenital malformations, and hydrocephalus associated with tumors. 
The Chhabra medium pressure “slit-valve” shunt donated by International Federation of Spina 
Bifida was used in the majority and Hakim-Codman and Integra in few cases prophylactic 
intravenous ceftriaxone was given preoperatively. 
 
Complications were classified as early: complications occurring between immediate 
postoperative period and discharge, Late: Complications in the follow-up period. Outcomes 
were graded as good, fair, or poor, according to visual, head circumference, and anterior 
fontanelle status, motor, and seizure criteria. Mortality was defined as death from any cause 
before discharge or within 30 days of the operation. Data was analyzed using computer-based 
software IBM SPSS statistical data editor version 20.0. Independent-samples T test for 
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dichotomized variables and one-way ANOVA for multiple comparisons were used. A p- value of 
< 0.05 was considered significant and ethical clearance was obtained from MCM. 
 
Results 
One hundred thirty-five patients were treated with VP shunt insertion our center. One hundred- 
fourteen patients ≤ 12 years of age treated with VP shunt insertion were included in the current 
study, of which 61(53.5%)were male and 46(46.5%) female. A slight male predominance was 
observed, in a male: female ratio, 1.2:1, and statistically insignificant (p=0.38). The median age 
of patients was 3.0 months and ranged from 1 day to 12 years, majority of the patients were 
below 1 year (71.1%) and 83% were below 4 years of age, mean age at shunt insertion being 
10.1±18.3 months with range, 0.3-144 months (Table 1). The mean head circumference at 
presentation was 50.4 ± 10.1cm (90th percentile) with a range, 34-106 cm. All patients had a 
radiologic investigation available before treatment, computed tomography scan results were 
available for 59(51.8.%) patients, brain MRI was used in 9(7.9%) patients and brain ultrasound 
was method of investigative modality in 36(31.6%)patients (infants with open fontanelle). The 
mean time delay from admission to the first VP shunt insertion was 4 ± 5.06 days (range 1-20). 
 
Table 1. Socio-demographic Characteristics of Patients with Hydrocephalus in MCM,  
Addis Ababa: 2011 – 2012. 
Age (months) Male (%) Female (%) Total (%) 
<3.0  28(20.7) 30(22.2) 58(43.0) 
>3-6  8(5.9) 6(4.4) 14(10.4) 
>6-12  15(11.1) 9(6.6) 24(17.8) 
>12-24  3(2.2) 1(0.7) 4(2.9) 
>24-48 3(2.2) 5(3.7) 8(5.9) 
>48-96 2(1.5) 2(1.5) 4(2.9) 
96+ 1(0.7) 0(0.0) 1(0.7) 
Total 61(54.1) 53(45.9) 114(100.0) 
Mean=10.12±18.3(range, 0.3-144 months 
Median=3.0 months 
 
Table 2. Percentage of the Various Causes of Patients with Hydrocephalus in MCM,  
Addis Ababa: 2011 – 2012. 
 
Age (mos) SB CMII DWM PIH CAS Masses Total 
≤3.0 31(27.2) 12(10.5) 3(2.6) 8(7.0) 2(1.8) 1(0.7) 58(50.9) 
3.1-6.0 8(7.0) 0(0.0) 0(0.0) 3(2.6) 2(1.8) 1(0.7) 14(12.3) 
6.1-9.0 5(4.4) 0(0.0) 0(0.0) 3(2.6) 2(1.8) 5(4.4) 15(13.1) 
9.1-12.0 2(1.8) 0(0.0) 0(0.0) 5(4.4) 2(1.8) 0(0.0) 9(7.9) 
12+ 3(2.6) 1(0.7) 5(4.4) 4 2(1.8) 3(2.6) 18(15.8) 
Total 49(42.9) 14(12.3) 8(7.0) 23(20.2) 10(8.8 10(8.8) 114(100.0) 
 
SB - Spina Bifida, CMII - Chiari Malformation type 2, DWM- Dandy Walker Malformation, PIH - 
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Table 3. Distribution of early and late complications among the various age groups of 
Hydrocephalicpatients treated with VP shunt insertion in MCM, Addis Ababa: 2011 – 2012 
Complications Age Group (%) 
Early=114 0-6 mos 6-12 mos 12+ mos Total (%) 
    Cardiorespiratory arrests 2(1.8.) 1(0.9)  0(0.0) 3(2.6) 
    Aspiration pneumonia 1(0.9) 1(0.9)  0(0.0) 2(1.8) 
Death 2(1.8) 0(0.0) 0(0.0) 2(1.8) 
Total 5(4.4) 2(0.7)  0(0.0) 7(6.1) 
Late, n=112     
None 30(26.8) 12(10.5) 7(6.2) 49(43.8) 
Undershunting 30(26.8)  6(5.4) 9(8.0) 45(40.2) 
Infection  3(2.8)  4(3.8)  1(0.9) 8(5.2) 
Overhunting  4(3.8)  0(0.0)  0(0.0) 4(3.8) 
Seizure 1(0.7) 1(0.9)  1(0.9) 3(2.8) 
Distal catheter problem 1(0.9) 1(0.9)  0(0.0) 2(1.8) 
Skin break down  1(0.9)  0(0.0)  0(0.0) 1(0.9) 
Extrusion via anus 1(0.9)  0(0.0)  0(0.0) 1(0.9) 
Lost vent catheter 1(0.9)  0(0.0)  0(0.0) 1(0.9) 
Total 72(54.0) 24(20) 18(25.9) 114(100.0) 
 
 
Figure 1. Typical patient in this series with severe 
Macrocephaly (HC, 63cm) and sunsetting of the eyes. 
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Table 4. Condition on discharge and outcome at 6 months of Hydrocephalus  
Patients treated with VP shunt insertion, Addis Ababa: 2011 – 2012 
Condition Frequency Percentage 
Improved 101 88.6 
Same 9 7.9 
Deteriorated 2 1.8 
Death 2 1.8 
Total 114 100.0 
Outcome   
Good 53 46.5 
Fair 6 5.3 
Poor 1 0.9 
Total 60 52.6 
 
 
Figure 2. Pie chart showing the Various Aetiologies in 114 Patients with Hydrocephalus. 
SB=spina bifida, DWM= dandy walker malformation. 
 
The causes of hydrocephalus identified in 114 patients include spina bifida, Chiari and Dandy 
walker malformation, and post infectious, congenital aqueductal stenosis, brain tumors. Spina 
bifida was significant cause of hydrocephalus in 42.3% patients (p=0.001) followed by post 
infection and Chiari malformation II in 20.2% and 12.3 %respectively (figure 1 and Table 2). 
Communicating type of hydrocephalus was seen in 34 patients (29.8%) and 80patients (70.2%) 
had non-communicating type of hydrocephalus 
 
The ventricular insertion site was frontal in 70 patients (61.4%), parietal in 9 patients (7.9%) 
and occipital in 35 patients (30.7%). Three types of shunts were used Chhabra, Codman and 
Integra. Most patient 107(93.9%) received Chhabra shunts. In 114 patients with hydrocephalus, 
141 VP shunt insertion procedures were done, 93(81.6%) were primary VP shunt insertions, 17 
(14.9%) were revised once, 3 (3.5%) twice; and one patient had four revisions.  
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The surgery for VP shunt insertion went smoothly for 105 patients (92.1%). Four intraoperative 
complications were noted, such as bleeding and cardiorespiratory arrest and early 
postoperative complications including death were recorded in 5(4.4%) patients     (Table 3). 
Early complications following surgery were seen in 65(57.0%) patients. The commonest 
complication was mechanical failure in 54(48.2%) patients, under shunting constituted 83.3% 
(45/54) of the mechanical shunt failure and 40% of the overall complications, 38/65 (58.5%) 
and 30/65(46.2%) of the under shunting occurred in the age group 0-6 months. Rare 
complications like extrusion via anus and lost ventricular catheter were seen in one patient each 
(figure 2). Shunt infection was demonstrated in only 7 patients (6.1%). The in-hospital mortality 
was recorded in 2(1.8%) patients. On discharge, 97/112 patients (86.6%) improved clinically 
and 9 patients (8.9%) were in the same condition, 2(1.8%) deteriorated. 
 
All patients had 100% follow-up on their first visit within the first one-month after discharge, 
89/112 patients (79.5%) had follow-up for the first 3 months, 87/112(53.4%) for 6 months, 
mean duration of follow-up was 6.8 ± 7.2(range 1-36 months). The follow-up rate at one year 
was 17.5%. 
 
The shunt function rate at 6 months was good in 53/60 (88.3%) patients, because these patients 
had normal vision, motor activity, and decrement in head circumference, soft fontanelle and no 
seizures. Patients with a head circumference greater than 50 cm had significant early 
complication compared to those with ≤ 50 cm after VP shunt insertion (p=0.028).No significant 
age difference was noted between patients with complication and without complication 
(p=0.7);age was not also significantly correlated to the early outcome (p=0.76).Sex was 





Figure 3. Extrusion of Peritoneal Catheter through Anus in 1-year-old Female Patient  
 
Discussion 
The mean and median age of patients at shunt insertion was 10.1±18.3 (range 0.3-144 months)  
and 3.0 months respectively,71.1% of the patients were below 1 year and 83% were below 4 
years of age, this agrees well with Warf (2005), and Gathura et. al (2010) who  reported mean 
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age of 13.3 months, 88% 1 year or younger and median age 3.3 months,84.6% of the children 
were younger than 1 year old  repectively2,3,7. 
 
Fifty-four percent of the patients were male in our study, which is consistent with a previously 
reported male preponderance in hydrocephalus3,8,9.  Gathura et. al, reported that female patients 
are more likely to develop infectious complications, but our results showed no significant 
relationship between sex and complications. This relationship has not been previously 
documented as well9-11. 
 
Imaging modalities such as CT and MRI are done in 65.1%, which makes accurate diagnosis 
possible and better compared to studies conducted in East Africa2,3. This might have contributed 
to a lesser mortality rate as compared to these studies. But cranial ultrasonography (US) is also 
an essential diagnostic tool in developing countries; it can readily assess ventricular size and it 
is relatively inexpensive2. 
 
The causes of hydrocephalus in the developed countries are intraventricular hemorrhage and 
congenital hydrocephalus. Most studies in developing countries report infection as a cause of 
hydrocephalus2, 12. In this study most cases are associated with spina bifida (49.7%) similar to a 
study done in Kenya 3. This finding is strongly associated with rampant malnutrition in women 
of childbearing age. These women are also prone in developing folate deficiency, which is highly 
associated with increased occurrence of neural tube defects. 
 
The most common surgical intervention to treat hydrocephalus is the insertion of a VP shunt 
and yet, VP shunts are associated with a high rate of complications all over the world, with 
failure rates reaching up to 40% within the 1st year of insertion. In this study, the over all early 
complication rate was 57.0% and is higher than the rate reported in studies done from Africa, 
Malaysia, Canada and Europe3-7, 13,17-22. High complication rate compared to not only Western 
literature but also Sub-Saharan Africa could be explained as follows, our patients present with 
severe malnutrition, advanced disease, poor skin integrity. Delay in surgical intervention, and 
generally physical debilitation is also routinely seen in our patients2, 3,7. The infection rate was 
7% and is comparable to the rate in the developed nations, which is reported to be 2 - 9%. 
3,11,14Young age has previously been identified as a major risk factor for shunt infection, and our 
infection rate of 7% is in line with published results for infants.15, 16,24 An overall infection rate of 
5 to 10% without regard to risk factors is considered acceptable, and commonly reported in the 
literature15. 
 
At MCM, common techniques to avoid shunt infection include the use of generous skin 
preparation, meticulous and consistent surgical technique, improving intraoperative factors like 
double gloving, Ioban dressing of the operative site, flushing the shunt with gentamycin and the 
avoidance of shunt-to-skin contact and preoperative prophylactic antibiotics2, 3,16,23,25 
 
The other important complication is mechanical failure seen in 47.4%, higher than a multicenter 
study from Canada which reported 40% mechanical failure17 and most reports2,3. In general high 
rate of mechanical failure could be due to the limited experience of the surgeon doing the 
procedure and the number of shunt procedures done at the center.16 Hence, considering these 
complications endoscopic third ventriculostomy presents a plausible option in the management 
of hydrocephalus2. 
 
The overall surgical mortality rate in this study is 1.8%, it is lower than reported in Sub-Saharan 
studies such as Kenya (6%)3 and Uganda (5.3%). 2,7 Although the true figure was probably 
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higher considering the likelihood of death in patients lost to follow-up.3Eventhough, survival 
and long-term mortality rates are not included in this review because extremely low one-year 
follow-up rate (17.5%), our results would have been not far from reports documented in most 
African counties. A recent study from Zimbabwe revealed a medium-term survival (over 2 
years) of only 33%–47% of patients18, and one-year mortality rate of 16% by Warf 7. Unlike to 
the report by Gathura et al3. Age and sex were not significantly correlated to the occurrence of 
early complication, less complications rates were observed in patients with head circumference 
≤ 50 cm compared to > 50 cm., this is in agreement with study conducted in East Africa 2,3. 
 
Shunt function rate of 88.3% at mean follow-up period of 6.8 months is higher than reported by 
Gathura et al3 and others who reported shunt function rate of 65% at 2 years. It is too early to 
compare ours to most studies with relatively longer period of follow-up duration2. This study 
only dealt with short-term outcomes, which makes it difficult to reach to shunt failure rates in 
our set up. Long-term follow up requires a few years of data collection and acceptable follow-up 
rates. There was a high dropout rate from follow up in this study, which introduces bias on the 
overall outcome and mortality rates. 
 
Our definition of “good outcome” as the absence of seizures, motor difficulties, or visual 
problems, decrement in head circumference, soft fontanelle is at best an assumption, since 
intellectual development and QOL include multiple other unmeasured factors. Our follow-up 
was short and middle term.  
 
Conclusion 
In a developing country such s Ethiopia, clinical symptoms and signs and cranial ultrasound are 
sufficient for the diagnosis and management of children with hydrocephalus. Spina bifida was 
main etiological cause of hydrocephalus in our setting. 
 
Our study done in a resource-limited African setting has documented good outcomes at 6 
months follow-up period for VP shunt insertion with acceptable early complication rates. 




The association of neural tube defects with hydrocephalus also mandates their prevention. 
Advocacy of all stakeholders for food fortification with folate is highly recommended. 
Alternative methods of treatment like ETV need to be strengthened in the training of residents 
who are major players in the treatment of children with hydrocephalus. 
Given the significant complication rates of VP shunts, ETV presents an attractive option in the 
management of hydrocephalus. Shunts, on the other hand are widely available and effective in 
the management of hydrocephalus. Considering the availability of reasonably priced or even 
fully subsidized VP shunts, and use of ETV is limited by expensive equipment and a paucity of 
available expertise, shunts will continue to play a pivotal role in the management of 
hydrocephalus in Ethiopia.  
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